DEBRA CONNELL-DENT: Open Payments
NPI 1558904508 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 10 payments from 9 companies in 2025. Trend: 2023 $791 · 2024 $732 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Medtronic, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: XIFAXAN, LEQVIO, MOUNJARO, INCEPTIV, PREVNAR 20, ZENPEP, Wegovy, JARDIANCE.
Industry payments across MO — which companies pay providers there.
